ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Prana Biotechnology REACH2HD Investor Confer, page-2

  1. 357 Posts.
    lightbulb Created with Sketch. 18
    re: Ann: Prana Biotechnology REACH2HD Investo... What is everyone's thoughts on this? How usual is it to hold a press conference regarding announcing trial results like this?
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.